跳转至内容
Merck
CN
  • The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.

The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.

Scientific reports (2020-10-31)
Neel Dhingani, Conghui Guo, Jie Pan, Qi Li, Neil Warner, Sasha Jardine, Gabriella Leung, Daniel Kotlarz, Claudia Gonzaga-Jauregui, Christoph Klein, Scott B Snapper, Víctor Manuel Navas-López, Aleixo M Muise
摘要

Very early onset inflammatory bowel disease (VEOIBD) denotes children with onset of IBD before six years of age. A number of monogenic disorders are associated with VEOIBD including tetratricopeptide repeat domain 7A (TTC7A) deficiency. TTC7A-deficiency is characterized by apoptotic colitis in milder cases with severe intestinal atresia and immunodeficiency in cases with complete loss of protein. We used whole exome sequencing in a VEOIBD patient presenting with colitis characterized by colonic apoptosis and no identified known VEOIBD variants, to identify compound heterozygous deleterious variants in the Ubiquitin protein ligase E3 component N-recognin 5 (UBR5) gene. Functional studies demonstrated that UBR5 co-immunoprecipitates with the TTC7A and the UBR5 variants had reduced interaction between UBR5 and TTC7A. Together this implicates UBR5 in regulating TTC7A signaling in VEOIBD patients with apoptotic colitis.

材料
货号
品牌
产品描述

Sigma-Aldrich
蛋白酶抑制剂混合物粉末, for general use, lyophilized powder
Sigma-Aldrich
抗Myc标签抗体,克隆4A6, clone 4A6, Upstate®, from mouse
Sigma-Aldrich
Anti-UBR5 Antibody, clone 16G10.1, clone 16G10.1, from mouse